BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

862 related articles for article (PubMed ID: 12575831)

  • 1. Invasive drug delivery.
    Blömer U; Ganser A; Scherr M
    Adv Exp Med Biol; 2002; 513():431-51. PubMed ID: 12575831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for retargeted gene delivery using vectors derived from lentiviruses.
    Bartosch B; Cosset FL
    Curr Gene Ther; 2004 Dec; 4(4):427-43. PubMed ID: 15578992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal and viral vectors for gene therapy of the central nervous system.
    de Lima MC; da Cruz MT; Cardoso AL; Simoes S; de Almeida LP
    Curr Drug Targets CNS Neurol Disord; 2005 Aug; 4(4):453-65. PubMed ID: 16101560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral vectors for gene delivery to the central nervous system.
    Lentz TB; Gray SJ; Samulski RJ
    Neurobiol Dis; 2012 Nov; 48(2):179-88. PubMed ID: 22001604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.
    Lilley CE; Groutsi F; Han Z; Palmer JA; Anderson PN; Latchman DS; Coffin RS
    J Virol; 2001 May; 75(9):4343-56. PubMed ID: 11287583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for targeting lentiviral vectors.
    Frecha C; Szécsi J; Cosset FL; Verhoeyen E
    Curr Gene Ther; 2008 Dec; 8(6):449-60. PubMed ID: 19075628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gene therapy: new developments].
    Mohr L; Geissler M
    Praxis (Bern 1994); 2002 Dec; 91(51-52):2227-35. PubMed ID: 12564039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and molecular neurosurgery: pathways from concept to reality--part II: vector systems and delivery methodologies for gene therapy of the central nervous system.
    Zlokovic BV; Apuzzo ML
    Neurosurgery; 1997 Apr; 40(4):805-12; discussion 812-3. PubMed ID: 9092854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral vectors for gene therapy.
    Robbins PD; Ghivizzani SC
    Pharmacol Ther; 1998 Oct; 80(1):35-47. PubMed ID: 9804053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient gene transfer to neurons and glia: analysis of adenoviral vector performance in the CNS and PNS.
    Hermens WT; Giger RJ; Holtmaat AJ; Dijkhuizen PA; Houweling DA; Verhaagen J
    J Neurosci Methods; 1997 Jan; 71(1):85-98. PubMed ID: 9125378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of herpesvirus-based episomally maintained gene delivery vectors.
    Calderwood MA; White RE; Whitehouse A
    Expert Opin Biol Ther; 2004 Apr; 4(4):493-505. PubMed ID: 15102599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges of gene delivery to the central nervous system and the growing use of biomaterial vectors.
    Puhl DL; D'Amato AR; Gilbert RJ
    Brain Res Bull; 2019 Aug; 150():216-230. PubMed ID: 31173859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral-mediated gene transfer for cancer treatment.
    Wilson DR
    Curr Pharm Biotechnol; 2002 Jun; 3(2):151-64. PubMed ID: 12022258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of murine leukemia virus, human immunodeficiency virus, and adeno-associated virus vectors for gene transfer in multiple myeloma: lentiviral vectors demonstrate a striking capacity to transduce low-proliferating primary tumor cells.
    De Vos J; Bagnis C; Bonnafoux L; Requirand G; Jourdan M; Imbert MC; Jourdan E; Rossi JF; Mannoni P; Klein B
    Hum Gene Ther; 2003 Dec; 14(18):1727-39. PubMed ID: 14670124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular barriers to non-viral gene transfer.
    Lechardeur D; Lukacs GL
    Curr Gene Ther; 2002 May; 2(2):183-94. PubMed ID: 12109215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral vectors and delivery strategies for CNS gene therapy.
    Gray SJ; Woodard KT; Samulski RJ
    Ther Deliv; 2010 Oct; 1(4):517-34. PubMed ID: 22833965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer into the central nervous system in vivo using a recombinanat lentivirus vector.
    Lai Z; Brady RO
    J Neurosci Res; 2002 Feb; 67(3):363-71. PubMed ID: 11813241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing viral and non-viral gene transfer methods for genetic modification of porcine mesenchymal stem cells.
    Stiehler M; Duch M; Mygind T; Li H; Ulrich-Vinther M; Modin C; Baatrup A; Lind M; Pedersen FS; Bünger CE
    Adv Exp Med Biol; 2006; 585():31-48. PubMed ID: 17120775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing targeted gene delivery: chemical modification of viral vectors and synthesis of artificial virus vector systems.
    Boeckle S; Wagner E
    AAPS J; 2006; 8(4):E731-42. PubMed ID: 17285739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy of the central nervous system: general considerations on viral vectors for gene transfer into the brain.
    Serguera C; Bemelmans AP
    Rev Neurol (Paris); 2014 Dec; 170(12):727-38. PubMed ID: 25459120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.